Enjay: Good find. Interesting that the author, Theodore Zucconi, wrote a very positive SA article on LL in Sept,2019. As you indicated, TZ is still long CYDY. His passing reference to CYDY/LL stuck me as an oblique heads up to MRK shareholders that LL may be the answer to management's search for a catalyst to revitalize MRK's moribund sp, which has stagnated for the past 30 months. A catalyst scenario involving LL makes much more sense to me than the developmental pill for mild covid that TZ expanded about in the 2nd half of the article.

I know the above speculation is a reach, but I just found it odd that Zucconi, who owns CYDY, but not MRK, and who doesn't disclose any intention to buy MRK shares in the new future, went to the trouble of writing this long article on MRK's failure to cash in on covid, with the curious inclusion of a LL tease.